The U.S. Department of Energy this month issued a request forproposal for project definition studies of a National BiomedicalTracer Facility (NBTF). The facility would create a domestic sourcefor radioisotopes produced by linear accelerators (SCAN
The U.S. Department of Energy this month issued a request forproposal for project definition studies of a National BiomedicalTracer Facility (NBTF). The facility would create a domestic sourcefor radioisotopes produced by linear accelerators (SCAN 4/21/93).
Nuclear medicine advocates claim that the NBTF is needed becauseof a shortage of domestically-produced radioisotopes. They successfullylobbied Congress to order the DOE to appropriate $2 million tofund the project definition studies, which would examine variousfactors involved in building the NBTF, such as cost, locationand construction schedule. The $2 million appropriation is likelyto be approved shortly.
The DOE is expected to approve five applications for fundingproject definition studies, with federal funding amounting to$300,000 per study. Applications must be received by Feb. 1, 1994.
The request for proposal was published in the Oct. 14 issueof the Federal Register.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.